Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the COVID-19 pandemic: A qualitative systematic review

por Adams, Alison, Blawatt, Sarin, MacDonald, Scott, Finnick, Rhys, Lajeunesse, Julie, Harrison, Scott, Byres, David, Schechter, Martin T., Oviedo-Joekes, Eugenia
Publicado 2023

The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods sys...

por Adams, Alison, Blawatt, Sarin, Magel, Tianna, MacDonald, Scott, Lajeunesse, Julie, Harrison, Scott, Byres, David, Schechter, Martin T., Oviedo-Joekes, Eugenia
Publicado 2023

The Impact of Injectable Opioid Agonist Treatment (iOAT) on Involvement in Criminalized Activities: A Secondary Analysis from a Clinical Trial in Vancouver, BC

por Dobischok, Sophia, Guh, Daphne, Marchand, Kirsten, MacDonald, Scott, Lock, Kurt, Harrison, Scott, Lajeunesse, Julie, Schechter, Martin T, Oviedo-Joekes, Eugenia
Publicado 2023

How Can We Raise Awareness of Physician’s Needs in Order to Increase Adherence to Management and Leadership Training?

por Voirol, Christian, Pelland, Marie-France, Lajeunesse, Julie, Pelletier, Jean, Duplain, Rejean, Dubois, Josee, Lachance, Silvy, Lambert, Carole, Sader, Julia, Audetat, Marie-Claude
Publicado 2021

“As long as that place stays open, I’ll stay alive”: Accessing injectable opioid agonist treatment during dual public health crises

por Jaffe, Kaitlyn, Blawatt, Sarin, Lehal, Eisha, Lock, Kurt, Easterbrook, Adam, MacDonald, Scott, Harrison, Scott, Lajeunesse, Julie, Byres, David, Schechter, Martin, Oviedo-Joekes, Eugenia
Publicado 2023